Hikma Pharmaceuticals (HIK) Health Care Sector

  • Latest quote

    1,703.00p (mid)

  • Current Change (%)

    3.31%

  • Price

    Bid: 1,703.00p

    Offer: 1,704.00p

  • Today

    High: 1,707.50p

    Low: 1,645.00p

  • This year

    High: 2,025.00p

    Low: 858.20p

  • Information

    Volume: 377,670

    Market Cap: £4104.23M



Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Hikma Pharmaceuticals RNS Feed

Title Release date
Director/PDMR Shareholding 10:11 - February 11, 2019
Total Voting Rights 15:43 - February 1, 2019
Hikma launches Mitomycin for Injection 09:00 - January 29, 2019
Hikma announces agreement with Sciecure Pharma 09:00 - January 3, 2019
Hikma launches Clobazam 09:00 - December 10, 2018
Total Voting Rights 10:30 - December 3, 2018
Hikma announces injectable licensing agreement 09:00 - November 27, 2018
Hikma launches Triazolam Tablets 09:00 - November 19, 2018
Holding(s) in Company 11:15 - November 13, 2018
Hikma announces agreement with Vectura 09:44 - November 8, 2018
Hikma announces agreement with Vectura 07:00 - November 8, 2018
Trading Statement 07:00 - November 8, 2018
Total Voting Rights 12:39 - November 1, 2018
Block listing Interim Review 16:30 - October 16, 2018
Total Voting Rights 10:53 - October 1, 2018

NOTE: This is based on 66 open tips for this company


Total Number of Share tips :

110

View all Hikma Pharmaceuticals Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today